| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
LGND
Ligand Pharma
|
Oct 29, 2026 | BUY |
Strong Buy
-11.1% avg upside
16 analysts
|
$357.00
10.67% Upside
|
-0.3% | Β· |
|
BLCO
Bausch + Lomb Corporation
|
Oct 29, 2026 | BUY |
Buy
+7.6% avg upside
20 analysts
|
$23.00
15.09% Upside
|
+3.4% | Β· |
|
TSE:BHC
Bausch Health Companies
|
Oct 29, 2026 | HOLD |
Buy
+386.9% avg upside
30 analysts
|
$13.97
21.83% Upside
|
-6.9% | Β· |
|
TSE:WELL
WELL Health Technologies Corp
|
Oct 13, 2026 | BUY |
Strong Buy
+65.5% avg upside
11 analysts
|
$7.00
67.54% Upside
|
-0.5% | Β· |
|
PCRX
Pacira Pharmaceuticals
|
Oct 08, 2026 | HOLD |
Hold
+11.8% avg upside
23 analysts
|
$36.50
0.22% Upside
|
+0.2% | Β· |
|
TSE:APTX
Apotex Health Corp.
|
Oct 06, 2026 | BUY |
Strong Buy
+21.9% avg upside
12 analysts
|
$43.00
28.74% Upside
|
+13.4% | Β· |
|
TSE:DHT.UN
DRI Healthcare
|
Sep 22, 2026 | BUY |
Strong Buy
+19.9% avg upside
8 analysts
|
$22.00
21.19% Upside
|
+5.3% | Β· |
|
TSE:GUD
Knight Therapeutics
|
Aug 07, 2026 | BUY |
Strong Buy
-17.1% avg upside
8 analysts
|
$11.00
2.31% Downside
|
+17.0% | Β· |
|
AUPH
Aurinia Pharmaceuticals
|
Aug 07, 2026 | HOLD |
Strong Buy
-4.6% avg upside
12 analysts
|
$16.00
3.98% Downside
|
+2.3% | Β· |
|
TSE:DR
Medical Facilities
|
Aug 07, 2026 | HOLD |
Buy
+17.5% avg upside
2 analysts
|
$19.00
29.44% Upside
|
+1.7% | Β· |
|
MNKD
MannKind
|
Aug 06, 2026 | HOLD |
Buy
+104.0% avg upside
22 analysts
|
$4.75
35.73% Upside
|
+6.2% | Β· |
|
VHI
Valhi
|
Mar 19, 2026 | BUY |
Sell
+60.3% avg upside
3 analysts
|
$7.87
44.31% Downside
|
+27.4% | Β· |
|
ONCY
Oncolytics Biotech
|
Nov 19, 2025 | BUY |
Strong Buy
+1479.8% avg upside
12 analysts
|
$3.50
722.81% Upside
|
-63.5% | Β· |
|
TLRY
Tilray
|
Oct 08, 2021 | HOLD |
Hold
+169.5% avg upside
24 analysts
|
$19.00
651.09% Upside
|
-69.8% | Β· |
|
FR:ABVX
Abivax SA
|
Jun 23, 2021 | BUY |
Strong Buy
-29.1% avg upside
4 analysts
|
$22.00
72.08% Downside
|
-63.1% | Β· |
|
ACHV
Achieve Life Sciences
|
Aug 04, 2016 | HOLD |
Strong Buy
+128.6% avg upside
16 analysts
|
$1.00
85.38% Downside
|
Β· | Β· |
|
IMRSQ
IMRIS
|
Nov 06, 2013 | HOLD |
Strong Buy
+289999900.0% avg upside
3 analysts
|
$2.30
229999899.94% Upside
|
Β· | Β· |
|
TSE:CSCI
COSCIENS Biopharma
|
Feb 05, 2009 | BUY |
Strong Buy
+102.4% avg upside
8 analysts
|
β | Β· | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.